MedTrace Logo

Sleeping Habits on Performance Following Sleep Deprivation

NCT05942664 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2024-12-06

No results posted yet for this study

Summary

The goal of this randomized crossover clinical trial is to determine if habitual sleeping habits can predict endurance performance following a night of partial sleep deprivation in healthy untrained, recreationally trained, and trained cyclists (18-50 years, \~50% females). The main questions it aims to answer are:

1. Can habitual sleeping habits predict, or do different types of sleepers alter, performance outcomes following sleep deprivation?
2. Does sleep deprivation alter blood pressure, heart rate, or metabolic responses during a 20-minute time trial, and/or are these altered amongst different types of sleepers?

* Participants will be asked to perform 4 performance tests (20-minute time trial), 2 for familiarization, and 2 testing visits (1 under normal sleep and 1 under partial sleep deprivation).
* For 1 week prior to each testing visit, sleep will be tracked using an ActiGraph device.

The investigators hypothesize that habitual early sleepers, poor sleepers, those with greater variability in sleep duration, and females will show the greatest impairments in performance following partial sleep deprivation.

Conditions

  • Sleep
  • Athletic Performance
  • Hemodynamics

Interventions

BEHAVIORAL

Sleep

Sleep will be restricted to 60% normal sleep duration

Sponsors & Collaborators

  • University of Guelph

    lead OTHER

Principal Investigators

  • Philip Millar · University of Guelph

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-26
Primary Completion
2024-05-05
Completion
2024-05-06

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05942664 on ClinicalTrials.gov